|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 413/14 | |
| C07D 417/14 | |||
| C07D 419/14 | |||
| C07D 495/04 | |||
| A61K 31/422 | |||
| A61P 9/00 | |||
| A61P 11/00 |
| (11) | Patento numeris | 3121177 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16162808.6 |
| Europos patento paraiškos padavimo data | 2012-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-01-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161498110 P | 2011-06-17 | US |
| (72) |
BROOKS, Carl, US
CHEUNG, Mui, US
EIDAM, Hilary, Schenck, US
GOODMAN, Krista, B, US
HAMMOND, Marlys, US
HILFIKER, Mark, A, US
HOANG, Tram, H, US
PATTERSON, Jaclyn, R, US
STOY, Patrick, US
YE, Guosen, US
|
| (73) |
GlaxoSmithKline Intellectual Property (No. 2) Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | COMBINATIONS OF TRPV4 ANTAGONISTS |
| COMBINATIONS OF TRPV4 ANTAGONISTS |